0 FDA grants priority review for controversial dengue vaccine, Dengvaxia
The US FDA has granted priority review for Sanofi Pasteur’s dengue vaccine, Dengvaxia®, despite its controversial past.
Browsing: Clinical > Travel Medicine
0 Shigellosis – an update on the vaccine pipeline
Globally, shigella is reported to be the third largest cause of diarrheal mortality in the under-fives. We take a look at some of the vaccines that have made it to clinical development and some of the challenges still facing this diarrheal disease.
0 US Olympians at Rio 2016 were not infected with Zika
Blood samples from US athletes and staff who travelled to Rio de Janeiro, Brazil, for the 2016 Summer Games were not infected with Zika virus but tested positive for other viral infections, including West Nile Virus, dengue and chikungunya.
0 Conference report – British Society for Parasitology Autumn Symposium
Missed out on attending the British Society for Parasitology’s Autumn Symposium? Read our report of the event here, including talks from Roy Anderson and David Molyneux.
0 Infographic: World Rabies Day – Zero cases by 2030?
To mark World Rabies Day take a look at our infographic highlighting the current rabies burden and summarizing the strategy aiming to ensure there are zero cases of dog-mediated rabies by 2030.
0 WHO reports chikungunya outbreak in Italy
As of September 14th, fourteen confirmed cases of chikungunya have been reported in Italy, specifically in Rome and the coastal area of the Lazio Region.
0 Infographic: Travel medicine
With decreasing global boundaries and subsequently increasing travel, we’ve taken a look at five of the most common infectious diseases posing a risk to travelers in our latest infographic.
0 Zika – an update on the vaccine pipeline
Is a Zika vaccine imminent? Editor, Martha Powell, provides an overview of the current Zika vaccine candidates in human clinical trials and how these vaccines are being assessed.
0 Mosquito-borne diseases – how can omics help characterize vectors?
In this exclusive opinion piece, the authors discuss how ‘OMICS’ can help to unravel molecular dynamics driving the complex biological process involved in disease transmission.
0 What impact does the sandfly nanobiome have on leishmaniasis development?
Martin Olivier, discusses how the nanobiome of vectors may impact the infectious processes of disease, highlighting his work on exosomes in sandflies and leishmaniasis.
